{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:26:00Z","timestamp":1791829560371,"version":"4.3.4"},"reference-count":327,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The tumor microenvironment is a dynamic, complex, and redundant network of interactions between tumor, immune, and stromal cells. In this intricate environment, cells communicate through membrane\u2013membrane, ligand\u2013receptor, exosome, soluble factors, and transporter interactions that govern cell fate. These interactions activate the diverse and superfluous signaling pathways involved in tumor promotion and progression and induce subtle changes in the functional activity of infiltrating immune cells.<\/jats:p><jats:p>The immune response participates as a selective pressure in tumor development. In the early stages of tumor development, the immune response exerts anti-tumor activity, whereas during the advanced stages, the tumor establishes mechanisms to evade the immune response, eliciting a chronic inflammation process that shows a pro-tumor effect.<\/jats:p><jats:p>The deregulated inflammatory state, in addition to acting locally, also triggers systemic inflammation that has repercussions in various organs and tissues that are distant from the tumor site, causing the emergence of various symptoms designated as paraneoplastic syndromes, which compromise the response to treatment, quality of life, and survival of cancer patients. Considering the tumor\u2013host relationship as an integral and dynamic biological system, the chronic inflammation generated by the tumor is a communication mechanism among tissues and organs that is primarily orchestrated through different signals, such as cytokines, chemokines, growth factors, and exosomes, to provide the tumor with energetic components that allow it to continue proliferating. In this review, we aim to provide a succinct overview of the involvement of cancer-related inflammation at the local and systemic level throughout tumor development and the emergence of some paraneoplastic syndromes and their main clinical manifestations. In addition, the involvement of these signals throughout tumor development will be discussed based on the physiological\/biological activities of innate and adaptive immune cells. These cellular interactions require a metabolic reprogramming program for the full activation of the various cells; thus, these requirements and the by-products released into the microenvironment will be considered. In addition, the systemic impact of cancer-related proinflammatory cytokines on the liver\u2014as a critical organ that produces the leading inflammatory markers described to date\u2014will be summarized. Finally, the contribution of cancer-related inflammation to the development of two paraneoplastic syndromes, myelopoiesis and cachexia, will be discussed.<\/jats:p>","DOI":"10.3389\/fendo.2022.929572","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:20:18Z","timestamp":1661145618000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":78,"title":["The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment"],"prefix":"10.3389","volume":"13","author":[{"given":"Dolores","family":"Aguilar-Cazares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Chavez-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Marroquin-Muci\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Perez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus J.","family":"Benito-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uriel","family":"Rumbo-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose S.","family":"Lopez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: Triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"16717","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: An approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2014.0082","article-title":"A randomized phase II study to assess the effectiveness of fluid therapy or intensive nutritional support on survival in patients with advanced cancer who cannot be nourished via enteral route","volume":"17","author":"Oh","year":"2014","journal-title":"J Palliat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97973","article-title":"Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.02.007","article-title":"Tissue architecture in tumor initiation and progression","volume":"8","author":"Almagro","year":"2022","journal-title":"Trends Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","article-title":"Solute carrier transporters: the metabolic gatekeepers of immune cells","volume":"10","author":"Song","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.201900008","article-title":"Exosomes: The indispensable messenger in tumor pathogenesis and the rising star in antitumor applications","volume":"3","author":"Wang","year":"2019","journal-title":"Adv Biosyst"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function , and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0994","article-title":"The biology of cancer exosomes: Insights and new perspectives","volume":"77","author":"Ruivo","year":"2017","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-14","article-title":"Exosomes: An overview of biogenesis, composition and role in ovarian cancer","volume":"7","author":"Beach","year":"2014","journal-title":"J Ovarian Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2020.03.69","article-title":"Role of microenvironmental acidity and tumor exosomes in cancer immunomodulation","volume":"9","author":"Boussadia","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00563","article-title":"Immunological approaches towards cancer and inflammation: A cross talk","volume":"9","author":"Qu","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","article-title":"Biogenesis and function of extracellular vesicles in cancer","volume":"188","author":"Bebelman","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1235106","article-title":"Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells","volume":"5","author":"Paul","year":"2016","journal-title":"OncoImmunology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/CCO.0000000000000420","article-title":"Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes","volume":"30","author":"Ronca","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-93","article-title":"Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses","volume":"12","author":"Obacz","year":"2013","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2021.03.015","article-title":"Small extracellular vesicles in cancer","volume":"6","author":"Abhange","year":"2021","journal-title":"Bioact Mat"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.1989.tb02747.x","article-title":"As based upon physiological and pathological histology","volume":"47","author":"Virchow","year":"2009","journal-title":"Nutr Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198612253152606","article-title":"Tumors: wounds that do not heal. similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00300","article-title":"Dysregulated expression of glycolipids in tumor cells: From negative modulator of anti-tumor immunity to promising targets for developing therapeutic agents","volume":"5","author":"Daniotti","year":"2016","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/835956","article-title":"Protumor activities of the immune response: Insights in the mechanisms of immunological shift, oncotraining, and oncopromotion","volume":"2013","author":"Chimal-Ram\u00edrez","year":"2013","journal-title":"J Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0952-7915(02)00007-9","article-title":"Innate immune recognition by stimulatory immunoreceptors","volume":"15","author":"Diefenbach","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02156","article-title":"Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer","volume":"11","author":"Sivori","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.002","article-title":"Natural killer cell-mediated immunosurveillance of human cancer","volume":"31","author":"Malmberg","year":"2017","journal-title":"Semin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.immuni.2017.06.002","article-title":"Human leukocyte antigen F presents peptides and regulates immunity through interactions with NK cell receptors","volume":"46","author":"Dulberger","year":"2017","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.07.008","article-title":"Sweet killers: NK cells need glycolysis to kill tumors","volume":"28","author":"Isaacson","year":"2018","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1489824","article-title":"Novel alternatives to extracellular vesicle-based immunotherapy \u2013 exosome mimetics derived from natural killer cells","volume":"46","author":"Zhu","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101988","article-title":"Immune surveillance properties of human NK cell-derived exosomes","volume":"189","author":"Lugini","year":"2012","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.698639","article-title":"Extracellular vesicles from the human natural killer cell line NK3.3 have broad and potent anti-tumor activity","volume":"9","author":"Cochran","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: A review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"biomark Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00391","article-title":"Interferon gamma induces changes in natural killer (NK) cell ligand expression and alters NK cell-mediated lysis of pediatric cancer cell lines","volume":"8","author":"Aquino-L\u00f3pez","year":"2017","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.722999","article-title":"Old and new players of inflammation and their relationship with cancer development","volume":"11","author":"Chavez-Dominguez","year":"2021","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: A double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.semcdb.2015.05.004","article-title":"Human mononuclear phagocyte system reunited","volume":"41","author":"Haniffa","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00924","article-title":"Dendritic cells and their role in immunotherapy","volume":"11","author":"Gardner","year":"2020","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.03.011","article-title":"C-myb+ erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages","volume":"42","author":"Hoeffel","year":"2015","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00384-5","article-title":"Tumor-derived exosomes: A new source of tumor rejection antigens","volume":"20","author":"Andr\u00e9","year":"2002","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u03b5 supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor\u2013induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4697","article-title":"Hypoxia and hypoxia-inducible factor-1\u03b1 modulate lipopolysaccharide-induced dendritic cell activation and function","volume":"180","author":"Jantsch","year":"2008","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaj2155","article-title":"mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation","volume":"357","author":"Sinclair","year":"2017","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2006.02483.x","article-title":"Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity","author":"Hao","year":"2007","journal-title":"Immunology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.02.011","article-title":"Exosomes as intercellular signalosomes and pharmacological effectors","volume":"81","author":"Record","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055700","article-title":"Antigen presentation by extracellular vesicles from professional antigen-presenting cells","volume":"36","author":"Lindenbergh","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ni854","article-title":"Indirect activation of na\u00efve CD4+ T cells by dendritic cell\u2013derived exosomes","volume":"3","author":"Th\u00e9ry","year":"2002","journal-title":"Nat Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40164-022-00289-8","article-title":"Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D\/NKG2D-l pathway to kill CML cells with or without T315I mutation","volume":"11","author":"Du","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.058","article-title":"T Cell help amplifies innate signals in CD8 + DCs for optimal CD8 + T cell priming","volume":"14","author":"Greyer","year":"2016","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","article-title":"Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells","volume":"32","author":"Pipkin","year":"2010","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100852","article-title":"Tissue-resident memory CD4 + T cells play a dominant role in the initiation of antitumor immunity","volume":"208","author":"Zhang","year":"2022","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1913940117","article-title":"CD29 identifies IFN-\u03b3\u2013producing human CD8 + T cells with an increased cytotoxic potential","volume":"117","author":"Nicolet","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4+ T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.619939","article-title":"Tumor-derived exosomes enriched by miRNA-124 promote anti-tumor immune response in CT-26 tumor-bearing mice","volume":"8","author":"Rezaei","year":"2021","journal-title":"Front Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30378","article-title":"MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling","volume":"236","author":"Roshani Asl","year":"2021","journal-title":"J Cell Physiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.04.007","article-title":"Metabolic plasticity of neutrophils: Relevance to pathogen responses and cancer","volume":"7","author":"Rogers","year":"2021","journal-title":"Trends Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04461-w","article-title":"Phosphoinositide 3-kinase\/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization","author":"Yang","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874589","article-title":"Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression","volume":"13","author":"Pu","year":"2022","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.572689","article-title":"Exosomal miRNA-16-5p derived from M1 macrophages enhances T cell-dependent immune response by regulating PD-L1 in gastric cancer","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010164","article-title":"Ferroptosis in cancer cell biology","volume":"12","author":"Bebber","year":"2020","journal-title":"Cancers"},{"key":"B71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: Gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat Res Mutat Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","journal-title":"Proc Natl Acad Sci U A"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1455706","article-title":"The myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta","volume":"20","author":"Shchors","year":"2006","journal-title":"Genes Dev"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14035338","article-title":"Exosomes as intercellular signaling organelles involved in health and disease: Basic science and clinical applications","volume":"14","author":"Corrado","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02103","article-title":"Cancer-derived exosomes as effectors of key inflammation-related players","volume":"10","author":"Othman","year":"2019","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.05.040","article-title":"New insights into the biological impacts of immune cell-derived exosomes within the tumor environment","volume":"431","author":"Shen","year":"2018","journal-title":"Cancer Lett"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.03.007","article-title":"IFN-\u03b3-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer","volume":"28","author":"Martini","year":"2010","journal-title":"Vaccine"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.05445-11","article-title":"NF-\u03baB protects cells from gamma interferon-induced RIP1-dependent necroptosis","volume":"31","author":"Thapa","year":"2011","journal-title":"Mol Cell Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0596","article-title":"Low-dose IFN\u03b3 induces tumor cell stemness in tumor microenvironment of non\u2013small cell lung cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901511","article-title":"The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis","volume":"183","author":"Carmi","year":"2009","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002901","article-title":"Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis","volume":"186","author":"Carmi","year":"2011","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1038\/s41467-019-11782-w","article-title":"A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control","volume":"10","author":"Sun","year":"2019","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.23","article-title":"The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling","volume":"6","author":"Nappo","year":"2017","journal-title":"Oncogenesis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0449","article-title":"Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"998","DOI":"10.4049\/jimmunol.0903372","article-title":"IFN-\u03b3 inhibits IL-4\u2013induced type 2 cytokine expression by CD8 T cells In vivo and modulates the anti-tumor response","volume":"185","author":"Apte","year":"2010","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-135871","article-title":"Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells","volume":"112","author":"Agaugu\u00e9","year":"2008","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"De Simone","year":"2015","journal-title":"Oncogene"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.12.1947","article-title":"IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1","volume":"22","author":"Lin","year":"2001","journal-title":"Carcinogenesis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158839","article-title":"Interleukin-6 induces vascular endothelial growth factor-c expression via src-FAK-STAT3 signaling in lymphatic endothelial cells","volume":"11","author":"Huang","year":"2016","journal-title":"PloS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.08.004","article-title":"Interleukin-8 in cancer pathogenesis, treatment and follow-up","volume":"60","author":"Alfaro","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39397","article-title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts","volume":"120","author":"Ginestier","year":"2010","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028548","article-title":"Targeting IL-10 family cytokines for the treatment of human diseases","volume":"11","author":"Wang","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Role of interleukin-10 in breast cancer","volume":"133","author":"Hamidullah","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.12.051","article-title":"Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway","volume":"68","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020167","article-title":"IL-12 family cytokines in cancer and immunotherapy","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.06.039","article-title":"TH17 cells in the big picture of immunology","volume":"120","author":"Schmidt-Weber","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"B101","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","article-title":"IL-1, IL-18, and IL-33 families of cytokines","volume":"223","author":"Arend","year":"2008","journal-title":"Immunol Rev"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.12329","article-title":"Inhibition of blood vessel formation in tumors by IL-18-polarized M1 macrophages","volume":"21","author":"Xing","year":"2016","journal-title":"Genes Cells"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31730","article-title":"Dual TGF-\u03b2 and PD-1 blockade synergistically enhances MAGE-A3-specific CD8 + T cell response in esophageal squamous cell carcinoma","volume":"143","author":"Chen","year":"2018","journal-title":"Int J Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000422","article-title":"PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer","volume":"8","author":"Shen","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-014-1231-2","article-title":"TGF-\u03b21 precursor and CD8 are potential prognostic and predictive markers in operated breast cancer","volume":"34","author":"Yu","year":"2014","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2121-4","article-title":"An IL-15 superagonist\/IL-15R\u03b1 fusion complex protects and rescues NK cell-cytotoxic function from TGF-\u03b21-mediated immunosuppression","volume":"67","author":"Fujii","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901277","article-title":"GM-CSF: A double-edged sword in cancer immunotherapy","volume":"13","author":"Kumar","year":"2022","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102286","article-title":"Granulocyte-colony stimulating factor related pathways tested on an endometrial ex-vivo model","volume":"9","author":"Rahmati","year":"2014","journal-title":"PloS One"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13445","article-title":"G-CSF \/ GM-CSF -induced hematopoietic dysregulation in the progression of solid tumors","volume":"12","author":"He","year":"2022","journal-title":"FEBS Open Bio"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600289","article-title":"VEGF-null cells require PDGFR \u03b1 signaling-mediated stromal fibroblast recruitment for tumorigenesis","volume":"23","author":"Dong","year":"2004","journal-title":"EMBO J"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012445","article-title":"Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells","volume":"5","author":"Kong","year":"2010","journal-title":"PloS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2022.130188","article-title":"Role of platelet-derived growth factor c on endothelial dysfunction in cardiovascular diseases","volume":"1866","author":"Grismaldo","year":"2022","journal-title":"Biochim Biophys Acta BBA - Gen Subj"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102446","article-title":"Role of cytokines and chemokines in angiogenesis in a tumor context","volume":"14","author":"Geindreau","year":"2022","journal-title":"Cancers"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S161302","article-title":"Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer","volume":"11","author":"Bai","year":"2018","journal-title":"OncoTargets Ther"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.12688\/f1000research.9025.1","article-title":"EGF receptor ligands: recent advances","volume":"5","author":"Singh","year":"2016","journal-title":"F1000Research"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/546318","article-title":"The role of epidermal growth factor receptor in cancer metastasis and microenvironment","volume":"2013","author":"Sasaki","year":"2013","journal-title":"BioMed Res Int"},{"key":"B119","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1038\/s41598-022-09060-9","article-title":"A toolkit for recombinant production of seven human EGF family growth factors in active conformation","volume":"12","author":"Ferreira","year":"2022","journal-title":"Sci Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020287","article-title":"Chemokines and their receptors: Multifaceted roles in cancer progression and potential value as cancer prognostic markers","volume":"12","author":"Do","year":"2020","journal-title":"Cancers"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2017.78","article-title":"Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages","volume":"97","author":"Krawczyk","year":"2017","journal-title":"Lab Invest"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0579","article-title":"CXCR3 + T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity","volume":"72","author":"Redjimi","year":"2012","journal-title":"Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J Exp Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I","article-title":"ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains","volume":"28","author":"Samson","year":"1998","journal-title":"Eur J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038844","article-title":"The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues","volume":"109","author":"Parolini","year":"2007","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2011.10.006","article-title":"Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis","volume":"92","author":"Eisinger","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194778","article-title":"More than an adipokine: The complex roles of chemerin signaling in cancer","volume":"20","author":"Goralski","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/annotation\/4dfd522c-f0fd-40db-aadc-44cbef367a40","article-title":"Correction: Chemerin is an antimicrobial agent in human epidermis","author":"Banas","year":"2013","journal-title":"PloS One"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28056","article-title":"The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis","volume":"12","author":"Dubois-Vedrenne","year":"2021","journal-title":"Oncotarget"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12295","article-title":"Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy","author":"Bhat","year":"2022","journal-title":"Cancer Commun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11846","article-title":"A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation","author":"Gowhari Shabgah","year":"2022","journal-title":"Cell Biol Int"},{"key":"B132","article-title":"Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism","volume":"8","author":"Helmlinger","year":"2002","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41467-020-16966-3","article-title":"Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01525-3","article-title":"Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p\/HIPK2\/ERK axis and sequestering IGF2BP1","volume":"40","author":"Zhai","year":"2021","journal-title":"Oncogene"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.141069","article-title":"Modulation of hypoxia-signaling pathways by extracellular long non-coding RNA regulator of reprogramming","author":"Takahashi","year":"2014","journal-title":"J Cell Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4218","article-title":"Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer","author":"Nishizawa","year":"2017","journal-title":"Int J Oncol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/biology10090918","article-title":"Isolation and identification of long non-coding RNAs in exosomes derived from the serum of colorectal carcinoma patients","volume":"10","author":"Ng","year":"2021","journal-title":"Biology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26410","article-title":"Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-jun activation","volume":"131","author":"Mendler","year":"2012","journal-title":"Int J Cancer"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01878","article-title":"Lactate induces pro-tumor reprogramming in intratumoral plasmacytoid dendritic cells","volume":"10","author":"Raychaudhuri","year":"2019","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00476","article-title":"Altered iron metabolism and impact in cancer biology, metastasis, and immunology","volume":"10","author":"Brown","year":"2020","journal-title":"Front Oncol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Diff"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-065X.1998.tb01574.x","article-title":"Ecto-enzyme and signaling functions of lymphocyte CD 7 3","volume":"161","author":"Resta","year":"1998","journal-title":"Immunol Rev"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol Rev"},{"key":"B146","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1385\/IR:36:1:91","article-title":"Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2\/NKp46-Activated NK cells: Involvement of protein kinase a isozyme I (PKA I)","volume":"36","author":"Raskovalova","year":"2006","journal-title":"Immunol Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-190934","article-title":"Adenosine promotes alternative macrophage activation via A2A and A2B receptors","volume":"26","author":"Cs\u00f3ka","year":"2012","journal-title":"FASEB J"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813144106","article-title":"CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth","volume":"106","author":"Augsten","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13809","article-title":"Chemokine (C-X-C motif) ligand 1 and CXCL 2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells","volume":"109","author":"Shi","year":"2018","journal-title":"Cancer Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.07.018","article-title":"CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression","volume":"75","author":"Unver","year":"2015","journal-title":"Cytokine"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.07.024","article-title":"CXCL1\u2013chemokine (C-X-C motif) receptor 2 signaling stimulates the recruitment of bone marrow\u2013derived mesenchymal cells into diffuse-type gastric cancer stroma","volume":"186","author":"Kasashima","year":"2016","journal-title":"Am J Pathol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.11.017","article-title":"Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer","volume":"443","author":"Deng","year":"2019","journal-title":"Cancer Lett"},{"key":"B153","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/bcr2869","article-title":"Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers","volume":"13","author":"Yan","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-018-0869-y","article-title":"Role of hypoxia-induced exosomes in tumor biology","volume":"17","author":"Shao","year":"2018","journal-title":"Mol Cancer"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40483","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","author":"Chalmin","year":"2010","journal-title":"J Clin Invest"},{"key":"B156","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12967-020-02662-9","article-title":"Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications","volume":"18","author":"Jafari","year":"2020","journal-title":"J Transl Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113239","article-title":"Emerging role of LINC00461 in cancer","volume":"152","author":"Zhang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC: Innate immunity","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur J Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003416","article-title":"Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer","volume":"10","author":"Xu","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2493","article-title":"Tumor-derived chemokine CCL5 enhances TGF-\u03b2\u2013mediated killing of CD8 + T cells in colon cancer by T-regulatory cells","volume":"72","author":"Chang","year":"2012","journal-title":"Cancer Res"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408197102","article-title":"Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-\u03b2 signals in vivo","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.4161\/onci.1.2.18481","article-title":"Tgf-\u03b21 produced by activated CD4 + T cells antagonizes T cell surveillance of tumor development","volume":"1","author":"Donkor","year":"2012","journal-title":"OncoImmunology"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41467-019-09416-2","article-title":"Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma","volume":"10","author":"Barilla","year":"2019","journal-title":"Nat Commun"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/path.4781","article-title":"Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma: Role of exosomal miR-24 in immune regulation of nasopharyngeal carcinoma","volume":"240","author":"Ye","year":"2016","journal-title":"J Pathol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01591","article-title":"Hypoxia-driven immunosuppressive metabolites in the tumor microenvironment: New approaches for combinational immunotherapy","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1177\/1010428318797880","article-title":"Colon cancer\u2013derived conditioned medium induces differentiation of THP-1 monocytes into a mixed population of M1\/M2 cells","volume":"40","author":"Sawa-Wejksza","year":"2018","journal-title":"Tumor Biol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-022-00303-0","article-title":"Key early proinflammatory signaling molecules encapsulated within circulating exosomes following traumatic injury","volume":"19","author":"Walsh","year":"2022","journal-title":"J Inflammation"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.7.651","article-title":"Dual roles of immune cells and their factors in cancer development and progression","volume":"7","author":"Zamarron","year":"2011","journal-title":"Int J Biol Sci"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3390\/biology9110376","article-title":"IL-6, NLR, and SII markers and their relation with alterations in CD8+ T-lymphocyte subpopulations in patients treated for lung adenocarcinoma","volume":"9","author":"Islas-Vazquez","year":"2020","journal-title":"Biology"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018898108","article-title":"Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion","volume":"108","author":"Iliopoulos","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B172","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54714-1","article-title":"Transcriptional repression of the GLUT4 and C\/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha","volume":"266","author":"Stephens","year":"1991","journal-title":"J Biol Chem"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1159\/000430314","article-title":"Effect of TNF-alpha on caveolin-1 expression and insulin signaling during adipocyte differentiation and in mature adipocytes","volume":"36","author":"Palacios-Ortega","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.7.5242","article-title":"TNF\u03b1-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPAR\u03b3 without effects on pref-1 expression*","volume":"138","author":"Xing","year":"1997","journal-title":"Endocrinology"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-03095-8","article-title":"A high serum-free fatty acid level is associated with cancer","volume":"146","author":"Zhang","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00715-3","article-title":"Mechanisms of tumor necrosis factor-\u03b1 (TNF-\u03b1) hyperalgesia","volume":"692","author":"Watkins","year":"1995","journal-title":"Brain Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.01.070","article-title":"TNF-\u03b1 differentially modulates ion channels of nociceptive neurons","volume":"434","author":"Czeschik","year":"2008","journal-title":"Neurosci Lett"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30127","article-title":"Exosomal tumor necrosis factor-\u03b1 from hepatocellular cancer cells (Huh-7) promote osteoclast differentiation","volume":"122","author":"Li","year":"2021","journal-title":"J Cell Biochem"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01412","article-title":"Structural basis of IL-1 family cytokine signaling","volume":"10","author":"Fields","year":"2019","journal-title":"Front Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176009","article-title":"Roles of IL-1 in cancer: From tumor progression to resistance to targeted therapies","volume":"21","author":"Gelfo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B182","first-page":"1","article-title":"\u201cIL-1 signaling in tumor microenvironment.,\u201d","volume-title":"Tumor microenvironment. advances in experimental medicine and biology","author":"Zhang","year":"2020"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12615","article-title":"Function and regulation of IL-1\u03b1 in inflammatory diseases and cancer","volume":"281","author":"Malik","year":"2018","journal-title":"Immunol Rev"},{"key":"B184","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of interleukin-1 family cytokines: Variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"B185","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12974-015-0239-2","article-title":"Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons","volume":"12","author":"Santoni","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4296","article-title":"Interleukin-1\u03b2 increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse model","volume":"11","author":"Huang","year":"2016","journal-title":"Oncol Lett"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091276","article-title":"Extracellular vesicles from human advanced-stage prostate cancer cells modify the inflammatory response of microenvironment-residing cells","volume":"11","author":"Mezzasoma","year":"2019","journal-title":"Cancers"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0313-2","article-title":"Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1\u03b2","volume":"17","author":"Chen","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.02.019","article-title":"High-pressure oxygen rewires glucose metabolism of patient-derived glioblastoma cells and fuels inflammasome response","volume":"506","author":"Arienti","year":"2021","journal-title":"Cancer Lett"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5071-5","article-title":"Exosomes derived from gastric cancer cells activate NF-\u03baB pathway in macrophages to promote cancer progression","volume":"37","author":"Wu","year":"2016","journal-title":"Tumor Biol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13046-020-01688-7","article-title":"Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression","volume":"39","author":"Liang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206759","article-title":"Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages","volume":"13","author":"Linton","year":"2018","journal-title":"PloS One"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2022","article-title":"Fatty acid\u2013induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01429-8","article-title":"The emerging role of interleukin 1\u03b2 (IL-1\u03b2) in cancer cachexia","volume":"44","author":"Laird","year":"2021","journal-title":"Inflammation"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.12.6448","article-title":"Differential effects of IL-1\u03b1 and IL-1\u03b2 on tumorigenicity patterns and invasiveness","volume":"171","author":"Song","year":"2003","journal-title":"J Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.545","article-title":"Tumour-derived interleukin 1\u03b1 (IL-1\u03b1) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells","volume":"76","author":"Fonsatti","year":"1997","journal-title":"Br J Cancer"},{"key":"B197","article-title":"\u201cMetabolic interactions between tumor and stromal cells in the tumor microenvironment","volume-title":"Tumor microenvironment: Cellular, metabolic and immunologic interactions. advances in experimental medicine and biology","author":"Mishra","year":"2021"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int J Biol Sci"},{"key":"B199","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","article-title":"Hepatic acute phase proteins \u2013 regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling","volume":"91","author":"Bode","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.15.5953","article-title":"Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro","volume":"86","author":"Ishibashi","year":"1989","journal-title":"Proc Natl Acad Sci"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.20.7251","article-title":"Interferon beta 2\/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells","volume":"84","author":"Gauldie","year":"1987","journal-title":"Proc Natl Acad Sci"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830180510","article-title":"Induction of rat acute-phase proteins by interleukin 6 in vivo","volume":"18","author":"Geiger","year":"1988","journal-title":"Eur J Immunol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830180513","article-title":"Action of recombinant human interleukin 6, interleukin 1\u03b2 and tumor necrosis factor \u03b1 on the mRNA induction of acute-phase proteins","volume":"18","author":"Andus","year":"1988","journal-title":"Eur J Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"154577","DOI":"10.1016\/j.cyto.2018.10.018","article-title":"Crosstalk between inflammatory mediators and endoplasmic reticulum stress in liver diseases","volume":"124","author":"Duvigneau","year":"2019","journal-title":"Cytokine"},{"key":"B206","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-8549-4_5","article-title":"Markers of inflammation","volume":"1803","author":"Germolec","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.6001\/actamedica.v25i4.3929","article-title":"Systemic and local inflammation in colorectal cancer","volume":"25","author":"Rumba","year":"2019","journal-title":"Acta Med Litu"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.292","article-title":"A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer","volume":"107","author":"Proctor","year":"2012","journal-title":"Br J Cancer"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12030593","article-title":"Systematic review of prognostic role of blood cell ratios in patients with gastric cancer undergoing surgery","volume":"12","author":"Schiefer","year":"2022","journal-title":"Diagnostics"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: Differential association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J Clin Oncol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow prognostic score: A decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.114","article-title":"Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection","volume":"21","author":"Yamamura","year":"2014","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2015.09.015","article-title":"Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy","volume":"15","author":"Kurahara","year":"2015","journal-title":"Pancreatology"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602998","article-title":"Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer","volume":"94","author":"Crumley","year":"2006","journal-title":"Br J Cancer"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2008.01.016","article-title":"C-reactive protein in liver cancer surgery","volume":"34","author":"Morris-Stiff","year":"2008","journal-title":"Eur J Surg Oncol EJSO"},{"key":"B216","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","article-title":"Versatile functions for IL-6 in metabolism and cancer","volume":"36","author":"Mauer","year":"2015","journal-title":"Trends Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3384","article-title":"Inflammatory networks underlying colorectal cancer","volume":"17","author":"Lasry","year":"2016","journal-title":"Nat Immunol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22888","article-title":"Novel mechanism of c-reactive protein for enhancing mouse liver innate immunity","volume":"49","author":"Inatsu","year":"2009","journal-title":"Hepatology"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.157016","article-title":"Human c-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation","volume":"28","author":"Van Vr\u00e9","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30732","article-title":"Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer: Biomarkers in the DOC","volume":"141","author":"Rasmussen","year":"2017","journal-title":"Int J Cancer"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.04.020","article-title":"Cardiorespiratory fitness, C-reactive protein and lung cancer risk: A prospective population-based cohort study","volume":"51","author":"Pletnikoff","year":"2015","journal-title":"Eur J Cancer"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23303","article-title":"Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes","volume":"87","author":"Komrokji","year":"2012","journal-title":"Am J Hematol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.07.005","article-title":"Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery","volume":"138","author":"Ataseven","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10040503","article-title":"Serum albumin redox states: More than oxidative stress biomarker","volume":"10","author":"Tabata","year":"2021","journal-title":"Antioxidants"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000155514.17715.39","article-title":"Inhibition of albumin synthesis in chronic diseases: Molecular mechanisms","volume":"39","author":"Chojkier","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00492-3","article-title":"Albumin selectively inhibits TNF\u03b1-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells","volume":"55","author":"Zhang","year":"2002","journal-title":"Cardiovasc Res"},{"key":"B227","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/jth.12131","article-title":"Transcription factors in late megakaryopoiesis and related platelet disorders","volume":"11","author":"Tijssen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"B228","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00439-013-1355-7","article-title":"A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects","volume":"133","author":"Shameer","year":"2014","journal-title":"Hum Genet"},{"key":"B229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9213074","article-title":"Mean platelet volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions","volume":"2019","author":"Korniluk","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S215361","article-title":"Prognostic significance of platelet-To-Lymphocyte ratio (PLR) and mean platelet volume (MPV) during etoposide-based first-line treatment in small cell lung cancer patients","volume":"11","author":"Shen","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B231","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.thromres.2012.09.017","article-title":"Differential regulation of fibrinogen \u03b3 chain splice isoforms by interleukin-6","volume":"131","author":"Rein-Smith","year":"2013","journal-title":"Thromb Res"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M304210200","article-title":"Functional analysis of interleukin 6 response elements (IL-6REs) on the human \u03b3-fibrinogen promoter","volume":"278","author":"Duan","year":"2003","journal-title":"J Biol Chem"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb03534.x","article-title":"Transcriptional control mechanism of fibrinogen gene expression","volume":"936","author":"Fuller","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S198419","article-title":"Prognostic significance of the ratio of fibrinogen and albumin in human malignancies: A meta-analysis","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B235","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12885-022-09439-x","article-title":"Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment","volume":"22","author":"Kubota","year":"2022","journal-title":"BMC Cancer"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.9738\/INTSURG-D-13-00118.1","article-title":"Glasgow Prognostic score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma","volume":"99","author":"Nozoe","year":"2014","journal-title":"Int Surg"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1245\/s10434-014-3533-9","article-title":"Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer","volume":"21","author":"Aurello","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2019.12.004","article-title":"Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pancreatic cancer","volume":"20","author":"Hoshimoto","year":"2020","journal-title":"Pancreatology"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S208839","article-title":"Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: A systematic review and meta-analysis","volume":"11","author":"Hu","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: A Glasgow inflammation outcome study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Cancer"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2113-0","article-title":"Comparison of the Glasgow prognostic score (GPS) and the modified Glasgow prognostic score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer","volume":"142","author":"Fan","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S167398","article-title":"Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II&ndash;III colorectal cancer patients","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01200","article-title":"C-reactive protein-to-Albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy","volume":"9","author":"Martin","year":"2019","journal-title":"Front Oncol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1177\/1559325819889814","article-title":"C-reactive protein to albumin ratio in colorectal cancer: A meta-analysis of prognostic value","volume":"17","author":"Zhou","year":"2019","journal-title":"Dose-Response"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005024","article-title":"Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort study","volume":"95","author":"Xiao","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12949","article-title":"Diagnostic value of serum D-dimer, CA 125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis","volume":"147","author":"Chen","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23935","article-title":"Distribution and reference interval establishment of neutral-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in Chinese healthy adults","volume":"35","author":"Wang","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200936","article-title":"Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer","volume":"13","author":"Cho","year":"2018","journal-title":"PloS One"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S138039","article-title":"Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer","volume":"10","author":"Song","year":"2017","journal-title":"OncoTargets Ther"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.763","article-title":"The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"110","author":"Troppan","year":"2014","journal-title":"Br J Cancer"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049123","article-title":"Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis","volume":"11","author":"Yang","year":"2021","journal-title":"BMJ Open"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.23","article-title":"Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study","volume":"114","author":"Grenader","year":"2016","journal-title":"Br J Cancer"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027244","article-title":"Predictive value of the monocyte-to-lymphocyte ratio in the diagnosis of prostate cancer","volume":"100","author":"Xu","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i31.4639","article-title":"Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients","volume":"26","author":"Jakubowska","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1159\/000505627","article-title":"Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios in Male breast cancer patients","volume":"98","author":"Huszno","year":"2020","journal-title":"Oncology"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2018.180715","article-title":"Normal reference intervals of neutrophil-To-Lymphocyte ratio, platelet-To-Lymphocyte ratio, lymphocyte-To-Monocyte ratio, and systemic immune inflammation index in healthy adults: a Large multi-center study from Western China","volume":"65","author":"Luo","year":"2019","journal-title":"Clin Lab"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i34.6261","article-title":"Systemic immune-inflammation index for predicting prognosis of colorectal cancer","volume":"23","author":"Chen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16553","article-title":"Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"B259","doi-asserted-by":"publisher","first-page":"399","DOI":"10.29271\/jcpsp.2021.04.399","article-title":"Systemic immune-inflammation index (SII) predicts pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"31","author":"Eraslan","year":"2021","journal-title":"J Coll Phys Surg Pak"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12995","article-title":"Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer","volume":"10","author":"Guo","year":"2019","journal-title":"Thorac Cancer"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-06798-2","article-title":"Prognostic value of systemic \u0131mmune \u0131nflammation \u0131ndex in patients with laryngeal cancer","volume":"278","author":"Atasever Akkas","year":"2021","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260988","article-title":"Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer","volume":"16","author":"Rice","year":"2021","journal-title":"PloS One"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184134","article-title":"The aggregate index of systemic inflammation (AISI): A novel prognostic biomarker in idiopathic pulmonary fibrosis","volume":"10","author":"Zinellu","year":"2021","journal-title":"J Clin Med"},{"key":"B264","article-title":"Early paraneoplastic syndrome in medical oncology: clinicopathological analysis of 1694 patients treated over 20 years","volume":"31","author":"Zuffa","year":"1984","journal-title":"Neoplasma"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103676","article-title":"Paraneoplastic syndromes review: The great forgotten ones","volume":"174","author":"Sardi\u00f1a Gonz\u00e1lez","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01540","article-title":"Regulation of the bone marrow niche by inflammation","volume":"11","author":"Mitroulis","year":"2020","journal-title":"Front Immunol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2724-5","article-title":"Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases","volume":"75","author":"Chiba","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B268","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.celrep.2019.11.004","article-title":"Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging, and inflammation","volume":"29","author":"Helbling","year":"2019","journal-title":"Cell Rep"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.3390\/cells10050968","article-title":"Myelopoiesis during solid cancers and strategies for immunotherapy","volume":"10","author":"Wildes","year":"2021","journal-title":"Cells"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.6867","article-title":"Tumor exosomes inhibit differentiation of bone marrow dendritic cells","volume":"178","author":"Yu","year":"2007","journal-title":"J Immunol"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"B273","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBP\u03b2 transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320753111","article-title":"Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3026","article-title":"T-cell\u2013secreted TNF\u03b1 induces emergency myelopoiesis and myeloid-derived suppressor cell differentiation in cancer","volume":"79","author":"Al Sayed","year":"2019","journal-title":"Cancer Res"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1425","article-title":"Transcriptional profiles and stromal changes reveal bone marrow adaptation to early breast cancer in association with deregulated circulating microRNAs","author":"Chiodoni","year":"2019","journal-title":"Cancer Res"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00556-w","article-title":"Implications of metabolism-driven myeloid dysfunctions in cancer therapy","volume":"18","author":"Strauss","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00509","article-title":"Sterol metabolism and transport in atherosclerosis and cancer","volume":"9","author":"Yamauchi","year":"2018","journal-title":"Front Endocrinol"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114595","article-title":"Can non-cholesterol sterols indicate the presence of specific dysregulation of cholesterol metabolism in patients with colorectal cancer","volume":"196","author":"Vladimirov","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B281","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S161746","article-title":"Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review","volume":"10","author":"Bao","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.998469","article-title":"Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response","volume":"4","author":"Levy","year":"2015","journal-title":"OncoImmunology"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.02.014","article-title":"Complications of splenectomy","volume":"121","author":"Cadili","year":"2008","journal-title":"Am J Med"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: From mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S261585","article-title":"Cancer cachexia: Definition, staging, and emerging treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"B290","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-cancerbio-030419-033642","article-title":"Cancer-associated cachexia: A systemic consequence of cancer progression","volume":"4","author":"Biswas","year":"2020","journal-title":"Annu Rev Cancer Biol"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01399","article-title":"Contribution of angiogenesis to inflammation and cancer","volume":"9","author":"Aguilar-Cazares","year":"2019","journal-title":"Front Oncol"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: A metabolic driver in the tumour landscape","volume":"44","author":"Ippolito","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"B293","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00421-017-3795-6","article-title":"Lactate metabolism: historical context, prior misinterpretations, and current understanding","volume":"118","author":"Ferguson","year":"2018","journal-title":"Eur J Appl Physiol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1002\/path.4218","article-title":"Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite","volume":"230","author":"Choi","year":"2013","journal-title":"J Pathol"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847258","article-title":"Energy metabolism in cachexia","volume":"20","author":"Rohm","year":"2019","journal-title":"EMBO Rep"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9794","article-title":"Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-\u03b1 expression in skeletal muscle","volume":"253","author":"Noguchi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int J Cancer"},{"key":"B298","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","article-title":"Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic apc min\/+ mouse","volume":"457","author":"Baltgalvis","year":"2009","journal-title":"Pfl\u00fcg Arch - Eur J Physiol"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9958","article-title":"Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"B300","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.09.066","article-title":"Exosomes of oral squamous cell carcinoma cells containing miR-181a-3p induce muscle cell atrophy and apoptosis by transmissible endoplasmic reticulum stress signaling","volume":"533","author":"Qiu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731386","article-title":"Pharmacological inhibition of HMGB1 prevents muscle wasting","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B303","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41420-022-00972-z","article-title":"GDF-15 in tumor-derived exosomes promotes muscle atrophy via bcl-2\/caspase-3 pathway","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discovery"},{"key":"B304","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43440-020-00179-y","article-title":"Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison","volume":"73","author":"Masi","year":"2021","journal-title":"Pharmacol Rep"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1430","article-title":"Anatomical locations of human brown adipose tissue","volume":"62","author":"Sacks","year":"2013","journal-title":"Diabetes"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.848394","article-title":"Metabolic reprogramming in adipose tissue during cancer cachexia","volume":"12","author":"Weber","year":"2022","journal-title":"Front Oncol"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000067","article-title":"Lipolysis and lipases in white adipose tissue \u2013 an update","volume":"59","author":"Bolsoni-Lopes","year":"2015","journal-title":"Arch Endocrinol Metab"},{"key":"B308","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/apm.2018.10.01","article-title":"Lipid metabolism in cancer cachexia","volume":"8","author":"Dalal","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B309","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","article-title":"The role of triglyceride lipases in cancer associated cachexia","volume":"19","author":"Das","year":"2013","journal-title":"Trends Mol Med"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198704000-00005","article-title":"Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer: The response to glucose infusion and parenteral feeding","volume":"205","author":"Shaw","year":"1987","journal-title":"Ann Surg"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat Med"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00629","article-title":"Systemic inflammation in cachexia \u2013 is tumor cytokine expression profile the culprit","volume":"6","author":"de Matos-Neto","year":"2015","journal-title":"Front Immunol"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31977","article-title":"Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133\/PRDM16 pathway","volume":"144","author":"Zhang","year":"2019","journal-title":"Int J Cancer"},{"key":"B315","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-017-3056-3","article-title":"Reduced adipogenesis after lung tumor exosomes priming in human mesenchymal stem cells via TGF\u03b2 signaling pathway","volume":"435","author":"Wang","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2021.0220","article-title":"Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C\/EPB\u03b2","volume":"19","author":"Liu","year":"2022","journal-title":"Cancer Biol Med"},{"key":"B317","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13163990","article-title":"Neural mechanisms of cancer cachexia","volume":"13","author":"Olson","year":"2021","journal-title":"Cancers"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1990.258.1.E65","article-title":"Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis","volume":"258","author":"Gwosdow","year":"1990","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"B320","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(10)70359-5","article-title":"Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis","volume":"62","author":"G\u0105dek-Michalska","year":"2010","journal-title":"Pharmacol Rep"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062890","article-title":"Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease","volume":"22","author":"Maccio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1007\/BF00311551","article-title":"Are cytokines possible mediators of cancer cachexia","volume":"26","author":"Noguchi","year":"1996","journal-title":"Surg Today"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S30891","article-title":"Cachexia index in advanced non-Small-Cell lung cancer patients","volume":"9","author":"Jafri","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161125","article-title":"The relationship between sarcopenia and systemic inflammatory response for cancer cachexia in small cell lung cancer","volume":"11","author":"Kim","year":"2016","journal-title":"PloS One"},{"key":"B325","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1038\/s41598-020-64282-z","article-title":"An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer","volume":"10","author":"Barker","year":"2020","journal-title":"Sci Rep"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072605","article-title":"Anti-inflammatory drugs as anticancer agents","volume":"21","author":"Zappavigna","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-037846","article-title":"Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2\u2013 versus IL-15\u2013activated NK cells","volume":"109","author":"Chiossone","year":"2007","journal-title":"Blood"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.929572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:20:30Z","timestamp":1661145630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.929572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":327,"alternative-id":["10.3389\/fendo.2022.929572"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.929572","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"929572"}}